Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing

, MT Newswires - 4:22 AM ET 3/28/2025 default

04:22 AM EDT, 03/28/2025 (MT Newswires) -- Graham G. Walmsley, Director, on March 25, 2025, executed a purchase for 200,000 shares in Akero Therapeutics ( AKRO ) for $8,787,921. Following the Form 4 filing with the SEC, Graham has control over a total of 1,202,168 common shares of the company, with 2,168 shares held directly and 1,200,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025046271/xslF345X05/ownership.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.